Literature DB >> 9409332

Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells.

X Wu1, A Shang, H Jiang, H N Ginsberg.   

Abstract

Oleic acid (OA) stimulates apolipoprotein B (apoB) secretion from HepG2 cells by protecting the nascent protein from rapid intracellular degradation. In contrast, the n-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid, have been shown to reduce apoB secretion by increasing its intracellular degradation in rat hepatocytes. We attempted to determine if OA and DHA have these opposite effects at the same point in the secretory pathway for apoB or if they act at different points in HepG2 cells. Unexpectedly, we found that when DHA (0.2 mmol/L) was incubated with HepG2 cells for 2 hours, it stimulated both triglyceride (TG) synthesis and apoB secretion significantly (the "stimulatory effect"). The stimulatory effect of DHA on apoB secretion was associated with decreased intracellular degradation of newly synthesized apoB. These acute effects of DHA on TG synthesis and apoB secretion paralleled those previously demonstrated with OA. After DHA was removed from the medium, however, both TG synthesis and apoB secretion rapidly decreased to a level that was significantly less than the control level (the "inhibitory effect"). At the same time, intracellular apoB degradation was significantly increased, and this degradation was efficiently prevented by proteasome inhibitors. Removal of DHA from the incubation resulted in inhibition of the incorporation of endogenous fatty acids into TG. In contrast, removal of OA from the media was not associated with any such inhibitory effect. The inhibitory effect of DHA on basal apoB secretion persisted at least 8 hours. These studies suggest that incubation of HepG2 cells with DHA has biphasic effects on TG synthesis and apoB secretion: an initial stimulation of TG synthesis is followed by inhibition of TG synthesis and increased apoB degradation. Although the stimulatory effect of DHA is apparent during short incubations of HepG2 cells, both effects would be expected to occur during long incubations, since fatty acid uptake by cells is rapid and efficient. Thus, long incubations of HepG2 cells with DHA could result in overall reduced apoB secretion compared with cells incubated in bovine serum albumin. If these findings are extrapolated to the in vivo situation, they can explain the ability of dietary n-3 fatty acids, which would be delivered to the liver intermittently, to reduce very low density lipoprotein secretion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409332     DOI: 10.1161/01.atv.17.11.3347

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  5 in total

Review 1.  Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update.

Authors:  Kembra Albracht-Schulte; Nishan Sudheera Kalupahana; Latha Ramalingam; Shu Wang; Shaikh Mizanoor Rahman; Jacalyn Robert-McComb; Naima Moustaid-Moussa
Journal:  J Nutr Biochem       Date:  2018-02-27       Impact factor: 6.048

2.  Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein.

Authors:  Benny Hung-Junn Chang; Lan Li; Antoni Paul; Susumu Taniguchi; Vijayalakshmi Nannegari; William C Heird; Lawrence Chan
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.

Authors:  Meihui Pan; Arthur I Cederbaum; Yuan-Li Zhang; Henry N Ginsberg; Kevin Jon Williams; Edward A Fisher
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

4.  Lipopolysaccharide derived from the rumen down-regulates stearoyl-CoA desaturase 1 expression and alters fatty acid composition in the liver of dairy cows fed a high-concentrate diet.

Authors:  Tianle Xu; Hui Tao; Guangjun Chang; Kai Zhang; Lei Xu; Xiangzhen Shen
Journal:  BMC Vet Res       Date:  2015-03-07       Impact factor: 2.741

5.  Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.

Authors:  Noemí Serra; Roser Rosales; Lluís Masana; Joan-Carles Vallvé
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.